收稿日期: 2025-11-21
网络出版日期: 2026-02-25
基金资助
江苏省科技计划专项资金重点项目(BE2022049)
Effect of dexmedetomidine assisted deep brain stimulation on cAMP/PKA signaling pathway in elderly patients with Parkinson′s disease
Received date: 2025-11-21
Online published: 2026-02-25
目的 探讨右美托咪定辅助脑深部电刺激术对老年帕金森病患者环磷酸腺苷/蛋白激酶A(cAMP/PKA)信号通路的影响。 方法 选取2021年1月至2025年1月南京医科大学附属脑科医院收治的行脑深部电刺激术治疗的150例老年帕金森病患者作为研究对象,以随机数字表法将所选患者分为A组(75例)和B组(75例)。B组麻醉诱导前泵注右美托咪定,A组泵注相同体积生理盐水,均观察至术后2周,并进行为期6个月的随访。比较两组围术期相关指标,丘脑底核(STN)频率、双侧丘脑底核电生理信号长度、坐标误差,围手术期血流动力学[麻醉诱导前(T0)、全身麻醉插管后(T1)、麻醉加深时(T2)],脑损伤情况(术前1 h、术后1 d),Ramsay镇静评分(入手术室时、手术开始前、术中定位测试时、手术结束时),帕金森综合征评分量表运动评分(UPDRS)、认知功能、cAMP/PKA信号通路(术前1 h、术后2周)。 结果 手术、意识消失及自主呼吸恢复时间在B组明显较短(P < 0.05)。B组STN频率、双侧STN电生理信号长度、坐标误差与A组组间比,差异无统计学意义(P > 0.05)。T0 ~ T2两组MAP、HR均呈现逐渐降低趋势,T1、T2时刻B组平均动脉压(MAP)、心率(HR)高于A组,T0 ~ T2两组脑电双频指数(BIS)则呈现先降低后升高趋势(P < 0.05),两组间BIS、不同时刻及两组间血氧饱和度(SpO2)比较,差异无统计学意义(P > 0.05)。较术前1 h,术后1 d两组血清中枢神经特异蛋白(S-100β)、神经元特异性烯醇化酶(NSE)、同型半胱氨酸(Hcy)水平均升高,但B组更低,血清尿酸(UA)水平则均降低,但B组更高(P < 0.05)。入手术室时至手术结束时,两组Ramsay镇静评分均呈现逐渐升高趋势,其中术中定位测试时和手术结束时B组Ramsay镇静评分高于A组(P < 0.05)。较术前1 h,术后2周单侧、双侧开关状态UPDRS评分均降低,其中B组更低(P < 0.05)。较术前1 h,术后2周两组蒙特利尔认知功能评估量表(MoCA)评分则均升高,B组更高(P < 0.05)。较术前1 h,术后2周两组血清cAMP、PKA水平均升高,B组更高(P < 0.05)。 结论 右美托咪定可稳定脑深部电刺激术治疗老年帕金森病患者围手术期血流动力学指标,调节cAMP/PKA信号通路,改善其脑损伤情况,同样具有良好靶点定位作用,缩短患者手术时间、意识消失时间及恢复时间,提高其镇静程度,提高患者认知功能及运动功能。
郑初蕾 , 章文斌 , 胡苏皖 , 张琪 , 刘存明 , 杨春 , 杨斯淇 , 李锦汶 . 右美托咪定辅助脑深部电刺激术对老年帕金森病患者cAMP/PKA信号通路的影响[J]. 实用医学杂志, 2026 , 42(4) : 579 -587 . DOI: 10.3969/j.issn.1006-5725.2026.04.006
Objective To investigate the effect of dexmedetomidine-assisted deep brain stimulation on the cAMP/PKA signal pathway in elderly patients with Parkinson's disease. Methods A total of 150 elderly patients with Parkinson's disease who underwent deep brain stimulation (DBS) at the Affiliated Brain Hospital of Nanjing Medical University from January 2021 to January 2025 were selected as the study subjects. The enrolled patients were randomly divided into Group A (75 cases) and Group B (75 cases) using the random-number table method. In Group B, dexmedetomidine was pumped before anesthesia induction, while in Group A, an equal-volume of saline was pumped. The patients were observed for 2 weeks after the operation and followed up for 6 months. The perioperative-related indicators of the two groups were compared, including subthalamic nucleus (STN) frequency, length of bilateral subthalamic nucleus physiological signals, coordinate error, perioperative hemodynamics [before anesthesia induction (T0), after general anesthesia intubation (T1), and during anesthesia deepening (T2)], brain injury indicators (1 h before surgery, 1 d after surgery), Ramsay sedation score (before entering the operating room, before surgery, during intraoperative localization testing, and at the end of surgery), motor score of the Parkinson's syndrome scoring scale (UPDRS), cognitive function, and cAMP/PKA signaling pathway (1 h before surgery, 2 weeks after surgery). Results The recovery times of operation, unconsciousness, and spontaneous breathing in Group B were significantly shorter (P < 0.05). There were no significant differences in STN frequency, bilateral STN electrophysiological signal length, and coordinate error between Group B and Group A (P > 0.05). The mean arterial pressure (MAP) and heart rate (HR) in the T0 ~ T2 groups showed a decreasing trend. At T1 and T2, the MAP and HR in Group B were higher than those in Group A. Meanwhile, the bispectral index (BIS) in the T0 ~ T2 groups showed a trend of first decreasing and then increasing (P < 0.05). There were no significant differences in BIS and SpO2 at different times and between the two groups (P > 0.05). Compared with one hour before operation and one day after operation, the levels of serum central nervous system - specific protein (S - 100β), neuron-specific enolase (NSE), and homocysteine (Hcy) in both groups were higher, but these levels were lower in Group B. In contrast, the level of serum uric acid (UA) was lower overall, but it was higher in Group B (P < 0.05). In both groups, the Ramsay sedation scores gradually increased from the time of entering the operating room until the end of the operation. At the time of the intraoperative localization test and the end of the operation, the Ramsay sedation scores in group B were significantly higher than those in group A (P < 0.05). When compared to the scores 1 hour before the operation and 2 weeks after the operation, the Unified Parkinson's Disease Rating Scale (UPDRS) scores in both the unilateral and bilateral switch states were lower, with a more pronounced decrease in group B (P < 0.05). Similarly, the scores on the Montreal Cognitive Assessment Scale (MoCA) in both groups were higher when compared to the pre-operation (1 hour before) and 2-week post-operation scores, particularly in group B (P < 0.05). Moreover, the levels of serum cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) in both groups were higher compared to those 1 hour before the operation and 2 weeks after the operation, especially in group B (P < 0.05). Conclusions Dexmedetomidine can stabilize the perioperative hemodynamic indexes, regulate the cAMP/PKA signaling pathway, and improve the indexes of brain injury in elderly patients with Parkinson's disease undergoing deep-brain stimulation. Additionally, dexmedetomidine exhibits a favorable target-positioning effect, which shortens the operation time, the time of consciousness disappearance, and the recovery time. It also enhances the degree of sedation and improves the cognitive and motor functions of patients.
| [1] | ANTENUCCI P, COLUCCI F, GOZZI A, et al. Rechargeable and Nonrechargeable Implantable Pulse Generators for Deep Brain Stimulation in Parkinson′s Disease: Long‐Term Experience[J]. Front Neurol, 2025, 2025(1): 6097313-6097313. doi: 10.1155/ANE/6097313 . |
| [2] | LEE J E, PADILLA A H D, FOMENKO A, et al. Reduction of alpha synuclein oligomers in preclinical models of Parkinson's disease by electrical stimulation in vitro and deep brain stimulation in vivo[J]. Brain Stimul, 2024, 17(2): 166-175. doi: 10.1016/J.BRS.2024.02.005 . |
| [3] | SCHOEN D, DEUTSCH S, MEHTA J, et al. Boundary complexity of cortical and subcortical areas predicts deep brain stimulation outcomes in Parkinson′s disease[J]. Nat Commun, 2025, 16(1): 5590-5590. doi: 10.1038/S41467-025-60695-4 . |
| [4] | RAMíREZ Z C, MORENO F C K, MORENO G, et al. The costs and benefits of deep brain stimulation in Parkinson's disease: A review and social network analysis[J]. Arq Neuropsiquiatr, 2025, 83(7): 1-11. doi: 10.1055/S-0045-1809996 . |
| [5] | AZGOMI F H, LOUIE H K, BATH E J, et al. Modeling and optimizing deep brain stimulation to enhance gait in Parkinson′s disease: Personalized treatment with neurophysiological insights[J]. NPJ Parkinsons Dis, 2025, 11(1): 173-173. doi: 10.1038/S41531-025-00990-5 . |
| [6] | 熊赤, 陈鹏, 蒋曼丽, 等. 帕金森病脑深部电刺激术后基于微电极记录结果远程程控的临床疗效分析[J]. 中华神经外科杂志, 2024, 6(4): 329-334. doi: 10.3760/cma.j.cn112050-20231110-00159 . |
| [7] | LI Z, YANG H. Intraoperative relief of resting tremor by dexmedetomidine in a patient with Parkinson's disease: A case report[J]. Asian J Surg, 2024, 47(4): 1951-1952. doi: 10.1016/J.ASJSUR.2023.12.162 . |
| [8] | 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 帕金森病基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2020, 19(1): 5-17. doi: 10.3760/cma.j.issn.1671-7368. 2020.01.003 . |
| [9] | 刘雨睿, 王勇, 李静静, 等. 2022年美国麻醉医师协会《困难气道管理实践指南》解读[J]. 临床麻醉学杂志, 2022, 38(6): 643-647. doi: 10.12089/jca.2022.06.016 . |
| [10] | 李其沛, 罗欣, 袁玉静, 等. 右美托咪定和舒芬太尼复合丙泊酚用于老年患者内镜逆行胰胆管造影术深度镇静的比较[J]. 临床麻醉学杂志, 2023, 39(12): 1282-1286. doi: 10.12089/jca.2023.12.009 . |
| [11] | 万赢, 肖仁清, 赵嘉豪, 等. 帕金森病运动并发症风险分层治疗方案的疗效评价[J]. 中华医学杂志, 2022, 102(7): 491-498. doi: 10.3760/cma.j.cn112137-20210930-02204 . |
| [12] | 刘月, 刘琦, 董惠, 等. 基于蒙特利尔认知评定量表双阈值定义的卒中后认知“恢复者”神经心理学变化研究[J]. 中国全科医学, 2023, 26(27): 3417-3422. doi: 10.12114/j.issn.1007-9572.2022.0885 . |
| [13] | 杨杰, 邓淑坤, 袁鹏, 等. 基于肠道菌群理论探讨益生菌联合运动康复在帕金森病患者中的疗效[J]. 实用医学杂志, 2025, 41(20): 3191-3197. doi: 10.3969/j.issn.1006-5725. 2025.20.007 . |
| [14] | SPAGNOLO D, SPITALE G. A Mixed-methods Study of Deep Brain Stimulation's Temporal Impact on Parkinson′s Disease Patients: Insights from Short-, Medium-, and Long-term Experiences[J]. Neuroethics, 2025, 18(2): 29-29. doi: 10.1007/S12152-025-09601-9 . |
| [15] | PIWOWARSKI K, SOBSTYL M, KARAMON K. Damage to the entire deep brain stimulation system after the standard replacement of an implantable pulse generator, probably due to self-injurious behavior in a patient with advanced Parkinson's disease[J]. Postep Psychiatr Neurol, 2025, 34(2): 124-129. doi: 10.5114/PPN.2025.151784 . |
| [16] | RAGU? M, TARLE M, MAR?INKOVI? P, et al. The Role of Preoperative Immunonutritional Scores in Predicting Complications After Subthalamic Nucleus Deep Brain Stimulation in Parkinson′s Disease[J]. J Clin Med, 2025, 14(11): 3811-3811. doi: 10.3390/JCM14113811 . |
| [17] | PETRALITO M, TEDESCO C, PUCCIARELLI G, et al. Education Programs for Patients With Parkinson's Disease Receiving Deep Brain Stimulation: A Scoping Review[J]. West J Nurs Res, 2025, 47(8): 786-796. doi: 10.1177/01939459251341814 . |
| [18] | LEE Y G, KWON Y H, PARK K, et al. Medication versus globus pallidus internus deep brain stimulation in Parkinson′s disease with deep learning video analysis of finger tapping[J]. Sci Rep, 2025, 15(1): 17557. doi: 10.1038/S41598-025-02098-5 . |
| [19] | 谭丽, 马羽, 吴康, 等. 基于机器学习探讨经脑深部电刺激术治疗后帕金森病围手术期中医证候变化[J]. 中华中医药杂志, 2023, 38(12): 6128-6132. doi: 10.6038/cjg2024R0854 . |
| [20] | 孟元元, 刘艳, 李俊, 等. 右美托咪定通过cGAS-STING通路介导的免疫调控机制对胃癌细胞恶性生物学行为的影响[J]. 中国免疫学杂志, 2024, 40(5): 945-951, 960. doi: 10.3969/j.issn.1000-484X.2024.05.008 . |
| [21] | 王晓宁, 张丽红, 张彤, 等. 持续输注超低剂量右美托咪定对老年CAS患者血流动力学和术后认知功能的影响[J]. 中国医科大学学报, 2024, 53(3): 193-197, 206. doi: 10.12007/j.issn.0258-4646.2024.03.001 . |
| [22] | TAKAFUMI S, HIROFUMI S, YOSHIKI U, et al. Epiretinal Membrane Surgery for a Patient with Dyskinesia Related to Parkinson's Disease Using Intravenous Dexmedetomidine Administration[J]. Case Rep Ophthalmol, 2022, 13(3): 976-980. doi: 10.1159/000527157 . |
| [23] | BAO-PING Z, LI W, XIAN-WEI W, et al. Dexmedetomidine protects against degeneration of dopaminergic neurons and improves motor activity in Parkinson's disease mice model[J]. Saudi J Biol Sci, 2021, 28(6): 3198-3203. doi: 10.1016/J.SJBS.2021.04.013 . |
| [24] | 余理想, 于振坤, 杨传宗, 等. 不同剂量瑞芬太尼联合右美托咪定对环杓关节脱位夹持式复位的影响[J]. 临床麻醉学杂志, 2024, 40(10): 1034-1038. doi: 10.12089/jca.2024.10.005 . |
| [25] | MORGAN L, AMANDA D, KELLY R, et al. Treatment of Acute Delirium in a Patient with Parkinson's Disease by Transfer to the Intensive Care Unit and Administration of Dexmedetomidine[J]. J Mov Disord, 2020, 13(2): 159-162. doi: 10.14802/jmd.20005 . |
| [26] | ANTONIO M, MIGUEL V, ELENA C, et al. Effects of dexmedetomidine on subthalamic local field potentials in Parkinson's disease[J]. Br J Anaesth, 2021, 127(2): 245-253. doi: 10.1016/J.BJA.2021.01.036 . |
| [27] | JUNG J H, CHUNG S J, YOO H S, et al. Sex-specific association of urate and levodopa-induced dyskinesia in Parkinson's disease[J]. Eur J Neurol, 2020, 27(10): 1948-1956. doi: 10.1111/ene.14337 . |
| [28] | 朱美琳, 程莉莉, 董有静. 右美托咪定在脑电双频指数指导及全身麻醉下帕金森病脑深部电刺激术中的应用[J]. 中国医科大学学报, 2021, 50(3): 276-279. doi: 10.12007/j.issn.0258-4646.2021.03.019 . |
/
| 〈 |
|
〉 |